CORCEPT THERAPEUTICS INC (CORT) › RevenueCORCEPT THERAPEUTICS INC (CORT) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $81.32M2017: $159.20M2018: $251.25M2019: $306.49M2020: $353.87M2021: $365.98M2022: $401.86M2023: $482.38M2024: $675.04M2025: $761.41M$761.41M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$761.41M+12.8%2024$675.04M+39.9%2023$482.38M+20.0%2022$401.86M+9.8%2021$365.98M+3.4%2020$353.87M+15.5%2019$306.49M+22.0%2018$251.25M+57.8%2017$159.20M+95.8%2016$81.32M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share